These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29260644)

  • 1. Recurrent renal cell carcinoma presenting as a solitary left ventricular mass.
    Wilde L; Mehrotra P; Hoffman-Censits J
    Can J Urol; 2017 Dec; 24(6):9145-9147. PubMed ID: 29260644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic cardiac metastasis responding to pazopanib in a patient with renal cell carcinoma.
    Behzadigohar R; Rosenthal MA; Tran B
    Can J Urol; 2015 Jun; 22(3):7824-6. PubMed ID: 26068633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity.
    Schinzari G; Monterisi S; Signorelli D; Cona MS; Cassano A; Danza F; Barone C
    Tumori; 2014; 100(6):e298-300. PubMed ID: 25688515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma.
    Santoni M; Conti A; Porta C; Procopio G; Sternberg CN; Basso U; De Giorgi U; Bracarda S; Rizzo M; Ortega C; Massari F; Iacovelli R; Derosa L; Masini C; Milella M; Di Lorenzo G; Atzori F; Pagano M; Buti S; De Vivo R; Mosca A; Rossi M; Paglino C; Verzoni E; Cerbone L; Muzzonigro G; Falconi M; Montironi R; Burattini L; Santini D; Cascinu S
    J Urol; 2015 Jan; 193(1):41-7. PubMed ID: 25046616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromophobe renal cell carcinoma with sarcomatoid dedifferentiation treated with pazopanib: a case report.
    Matrana MR; Ng C; Rao P; Lim ZD; Tannir NM
    Clin Genitourin Cancer; 2011 Dec; 9(2):137-9. PubMed ID: 21831725
    [No Abstract]   [Full Text] [Related]  

  • 6. Good tolerability, long-term survival and easy management of side effects in a patient with metastatic renal cell carcinoma treated with pazopanib.
    Frascaroli M; Di Cesare P
    Tumori; 2014; 100(6):e301-4. PubMed ID: 25688516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in personalised treatment of renal-cell carcinoma.
    Shariat SF; Xylinas E
    Lancet Oncol; 2012 Aug; 13(8):751-2. PubMed ID: 22759479
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged survival of a patient with papillary renal cell carcinoma and brain metastases using pazopanib.
    Jacobs C; Kim DW; Straka C; Timmerman RD; Brugarolas J
    J Clin Oncol; 2013 Mar; 31(7):e114-7. PubMed ID: 23319695
    [No Abstract]   [Full Text] [Related]  

  • 9. Pazopanib in renal cell carcinoma.
    Ward JE; Stadler WM
    Clin Cancer Res; 2010 Dec; 16(24):5923-7. PubMed ID: 21059813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials.
    Tran HT; Liu Y; Zurita AJ; Lin Y; Baker-Neblett KL; Martin AM; Figlin RA; Hutson TE; Sternberg CN; Amado RG; Pandite LN; Heymach JV
    Lancet Oncol; 2012 Aug; 13(8):827-37. PubMed ID: 22759480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell cancer metastases to esophagus and stomach successfully treated with radiotherapy and pazopanib.
    Cabezas-Camarero S; Puente J; Manzano A; Corona JA; González-Larriba JL; Bernal-Becerra I; Sotelo M; Díaz-Rubio E
    Anticancer Drugs; 2015 Jan; 26(1):112-6. PubMed ID: 25075797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pazopanib.
    Bukowski RM; Yasothan U; Kirkpatrick P
    Nat Rev Drug Discov; 2010 Jan; 9(1):17-8. PubMed ID: 20043026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pazopanib for the treatment of renal cancer.
    Al-Marrawi MY; Rini B
    Expert Opin Pharmacother; 2011 May; 12(7):1171-89. PubMed ID: 21470066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained ventricular tachycardia in renal cell carcinoma metastatic to anterior-apical wall of the left ventricle.
    Lanzillo T; Manganelli F; Rosato G; Rotondi F
    Europace; 2011 Nov; 13(11):1658. PubMed ID: 21712275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pazopanib in renal cell carcinoma.
    Sternberg CN
    Clin Adv Hematol Oncol; 2010 Apr; 8(4):232-3. PubMed ID: 20505644
    [No Abstract]   [Full Text] [Related]  

  • 16. First-line treatment of metastatic renal cell carcinoma after COMPARZ and PISCES.
    Schmidinger M; Wittes J
    Curr Opin Urol; 2015 Sep; 25(5):395-401. PubMed ID: 26148069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uveal metastasis and myasthenia gravis in a patient with recurrent renal cell carcinoma treated with pazopanib.
    Jebb A; Hadden P; Broom RJ
    Clin Genitourin Cancer; 2014 Aug; 12(4):e143-6. PubMed ID: 24656526
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tyrosine kinase inhibitor as adjuvant treatment of renal cell carcinoma: 1 versus 3].
    Penel N
    Bull Cancer; 2017 Sep; 104(9):705-706. PubMed ID: 28760312
    [No Abstract]   [Full Text] [Related]  

  • 19. Late isolated metastasis of renal cell carcinoma in the left ventricular myocardium.
    Talukder MQ; Deo SV; Maleszewski JJ; Park SJ
    Interact Cardiovasc Thorac Surg; 2010 Dec; 11(6):814-6. PubMed ID: 20847070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic renal cell carcinoma presenting as a cardiac tumour.
    Raiker NK; Jensen E; Wodzinski B; Maganti K
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30580304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.